{"id":1738,"date":"2024-08-22T15:18:30","date_gmt":"2024-08-22T21:18:30","guid":{"rendered":"http:\/\/liver.ca\/resource\/primary-biliary-cholangitis\/"},"modified":"2026-04-07T09:08:19","modified_gmt":"2026-04-07T13:08:19","slug":"cholangite-biliaire-primitive","status":"publish","type":"resource","link":"https:\/\/liver.ca\/fr\/resource\/primary-biliary-cholangitis\/","title":{"rendered":"Cholangite biliaire primitive"},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"template":"","meta":{"_acf_changed":false},"resource-topic":[47],"resource-type":[73],"class_list":["post-1738","resource","type-resource","status-publish","hentry","resource-topic-primary-biliary-cholangitis","resource-type-web"],"acf":{"type":73,"topic":[47],"blocks":[{"acf_fc_layout":"text","text":"Formerly known as Primary biliary cirrhosis, PBC is a disease that affects predominantly women aged 40-60. Thanks to improvements in our ability to treat and manage PBC, less than 50 percent of patients progress to cirrhosis. Because of this fact and the issue of \u2018cirrhosis\u2019 often being connected solely to alcohol, PBC patients around the world pushed for a name change. Hepatologists agreed with the need to change the name to more accurately reflect the nature of the disease.\r\n\r\nPrimary biliary cirrhosis is now known as primary biliary cholangitis. It permits the continued use of the short form PBC while providing a more accurate description of the disease. This change has been endorsed by Liver Canada, the Canadian Association for the Study of the Liver (CASL) as well as PBC patient groups and professional associations of liver specialists worldwide.\r\n\r\n<strong>What is Primary Biliary Cholangitis?<\/strong>\r\n\r\nPrimary biliary cholangitis, formerly known as primary biliary cirrhosis, is a chronic liver disease. When a person has PBC, the immune system attacks the liver causing slow, progressive damage to the bile ducts (small tubes through which bile flows out of the liver).\r\n\r\n<strong>Bile<\/strong>\u00a0is a yellow-green fluid produced by your liver to aid digestion. When the bile ducts are damaged, bile and other substances cannot be eliminated and accumulate in the liver. The retained substances are harmful to the liver and worsen the inflammation which leads to further damage. This can over time result in scarring of the liver. When there is a lot of scarring in the liver this is called cirrhosis.\r\n\r\nThe disease is called primary biliary cholangitis (PBC) because the immune system attacks the bile ducts inside the liver, which damages them. When immune cells surround and attack parts of the body, this is called inflammation. Inflammation of the bile ducts is called cholangitis. The medical term \u201cprimary\u201d in this case means that there is no known reason for this damage to happen. Because the disease blocks or prevents the flow of bile, PBC is known as a \u201ccholestatic\u201d liver disease.\r\n<figure id=\"attachment_3931\" class=\"wp-caption aligncenter\" aria-describedby=\"caption-attachment-3931\"><a href=\"https:\/\/interceptpharma.com\/\" rel=\"noopener\"><img class=\"wp-image-3931\" src=\"https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/Intercept_-_PBC_Liver_Progression.png\" sizes=\"(max-width: 600px) 100vw, 600px\" srcset=\"https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/Intercept_-_PBC_Liver_Progression.png 880w, https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/Intercept_-_PBC_Liver_Progression-300x109.png 300w, https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/Intercept_-_PBC_Liver_Progression-768x280.png 768w\" alt=\"A graphic showing Immune Response, Chronic cholestasis\/inflammation, fibrosis, and cirrhosis and end-stage liver disease. Image used with permission from Intercept Pharma.\" width=\"600\" height=\"219\" \/><\/a><figcaption id=\"caption-attachment-3931\" class=\"wp-caption-text\">Used with permission from Intercept Pharma. All rights reserved<\/figcaption><\/figure>\r\n<h2><strong>Who is at Risk?<\/strong><\/h2>\r\nPBC generally affects women between the ages of 40 and 60, but it has been diagnosed outside of this age range, as well as in men. Nine out of 10 people who get PBC are women. Although there is no evidence that PBC is inherited from mother to child, it is more common in the daughters of women with PBC.\r\n<h2><strong>Cause<\/strong><\/h2>\r\nThe cause(s) of PBC remains unknown, but current evidence suggests that PBC occurs in genetically predisposed people after exposure to an undetermined environmental factor. It is important to note that PBC is not caused by alcohol consumption.\r\n\r\nPBC is believed to be an autoimmune disease. In the case of PBC, your immune system which is designed to protect you against infections and cancer mistakes the bile duct cells as being not a normal part of the body and attacks them.\r\n\r\nSomething may trigger your body into making this mistake. Possible causes of this \u201ctrigger\u201d could be an infection or some form of toxin exposure from the environment.\r\n\r\nPBC usually develops and progresses slowly. Medication can slow its progression, especially if treatment begins early.\r\n<h2><strong>Could I Have It?<\/strong><\/h2>\r\nMany people with PBC have no symptoms. However, when they do, symptoms may vary and may be present in any combination and include:\r\n<ul>\r\n \t<li>mild to disabling chronic fatigue<\/li>\r\n \t<li>mild to intense and unrelenting itching of the skin (often on palms or soles of the feet)<\/li>\r\n \t<li>gradual darkening of the skin<\/li>\r\n \t<li>small white bumps under the skin, usually around the eyes.<\/li>\r\n<\/ul>\r\n<strong>Other symptoms, not directly related to PBC, are also often reported by patients:<\/strong>\r\n<ul>\r\n \t<li>dry membranes (nose, eyes, mouth, vagina)<\/li>\r\n \t<li>thyroid problems<\/li>\r\n \t<li>arthritis<\/li>\r\n \t<li>fingers and\/or toes that change colour in the cold (Raynaud\u2019s disease).<\/li>\r\n<\/ul>\r\nImportantly, many people with PBC never develop any symptoms related to the disease. Most commonly reported symptoms are fatigue and itching in any part of the body. Itching, also medically referred to as pruritus, may be the result of your liver\u2019s inability to process bile.\r\n\r\nIf liver damage progresses in PBC, other symptoms may appear, which can affect other parts of the body outside of the liver. These symptoms include:\r\n<ul>\r\n \t<li>enlarged abdomen from fluid accumulation (ascites)<\/li>\r\n \t<li>easy bruising or bleeding<\/li>\r\n \t<li>jaundice (yellowing of the skin and eyes)<\/li>\r\n \t<li>internal (gastrointestinal) bleeding<\/li>\r\n \t<li>bone pain or spontaneous fracture can also occur due to osteoporosis.<\/li>\r\n<\/ul>\r\n<h2><strong>Diagnosis<\/strong><\/h2>\r\nDiagnosis of PBC is typically made with specific blood tests:\r\n\r\nMost people with PBC have something in their blood called antimitochondrial antibody (AMA). An antibody is a protein made by your body\u2019s immune system to attack an \u201cinvader\u201d. The presence of AMA in your blood is an important sign that you have PBC.\r\n<ul>\r\n \t<li>Increased levels of alkaline phosphatase (ALP), an enzyme released into the blood by damaged bile ducts.<\/li>\r\n \t<li>Increased levels of the immunoglobulin IgM.<\/li>\r\n \t<li>The liver enzymes alanine transaminase (ALT) and aspartate transaminase (AST) are also monitored by your doctor although these enzymes are a measure of inflammation relating primarily to liver cell damage\/destruction, rather than bile duct cell damage.<\/li>\r\n<\/ul>\r\nIn addition, your healthcare provider may request other tests:\r\n<ul>\r\n \t<li>An abdominal ultrasound scan may be used to check the condition of the bile ducts, to make sure there is nothing else causing decreased bile flow out of the liver.<\/li>\r\n \t<li>A\u00a0liver biopsy\u00a0may be performed to see how serious your condition is. In this procedure, a small needle is inserted into the liver to take a sample of the tissue for analysis.<\/li>\r\n \t<li>A FibroScan\u00ae test (also called transient elastography), which is similar to an ultrasound test but gives information as to how stiff your liver is. The higher the stiffness (the number generated by the test), typically the more scarring there is in the liver.<\/li>\r\n<\/ul>\r\nPBC is a slow, progressive disease, which means that damage to the liver typically gets worse over a long period of time.\r\n<h2><strong>Treatment<\/strong><\/h2>\r\nPBC is a chronic liver disease. This means that PBC is a long-lasting condition that can currently be controlled in the majority of people, but not cured. The prognosis of PBC has improved over the last two decades due to earlier diagnosis and improved treatment. Early access to treatment can significantly delay progression of the disease. The outcome for PBC patients who are cholestatic and take treatment is better than for those who are not receiving treatment and can even be the same as people who do not have PBC.\r\n<ul>\r\n \t<li>A medication called ursodeoxycholic acid (also called UDCA, URSO) mimics a naturally occurring bile acid. This medication can improve liver function and delay the development of fibrosis (scar tissue) in the liver, which in turn can delay or eliminate the potential for PBC to progress towards liver failure and\/or liver transplantation.<\/li>\r\n \t<li>Vitamins A, D, E and K can be prescribed, usually when severe cholestasis and jaundice is present.<\/li>\r\n \t<li>Various medications may be prescribed by your doctor to help reduce itching. Some examples of these medications include cholestyramine, antihistamines or other medications.<\/li>\r\n \t<li>Complications of liver deterioration can often be controlled. As an example, a salt-restricted diet and medication (usually water pills) can be prescribed following accumulation of fluid in the abdomen.<\/li>\r\n<\/ul>\r\nA number of new medicines are currently being developed to treat PBC, typically to be added to UDCA therapy. Obeticholic acid (OCA), which is a man-made bile acid that acts to reduce liver inflammation and cholestasis, is available in Canada.\r\n\r\n<a href=\"https:\/\/liver.ca\/transplants\/\" rel=\"noopener\">Liver transplantation<\/a>\u00a0may be recommended for eligible candidates if other treatments are no longer helpful, and liver damage and scarring has progressed to the point that the liver is no longer able to work properly. Liver transplantation works well for people with PBC, although it is possible to develop PBC in your new liver.\r\n\r\n<strong>How do you know if your PBC treatment is working?<\/strong>\r\n\r\n<img class=\"aligncenter wp-image-3930 size-large\" src=\"https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/In_the_Know_infographic_Canadian_Liver_Foundation-710x1024.jpg\" sizes=\"(max-width: 640px) 100vw, 640px\" srcset=\"https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/In_the_Know_infographic_Canadian_Liver_Foundation-710x1024.jpg 710w, https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/In_the_Know_infographic_Canadian_Liver_Foundation-208x300.jpg 208w, https:\/\/liver.ca\/wp-content\/uploads\/2017\/10\/In_the_Know_infographic_Canadian_Liver_Foundation-768x1108.jpg 768w\" alt=\"Infographic with information about ALP and PBC\" width=\"640\" height=\"923\" \/>\r\n<h2><strong>How can I pay for my medication?<\/strong><\/h2>\r\n<strong>Private health insurance or drug plans<\/strong>\r\nIf you have private health insurance or a drug plan at work, you may be able to have the medication paid through your plan. Please consult your private health insurance or drug plan provider to see if your drug is covered.\r\n\r\n<strong>Publicly funded drug plans<\/strong>\r\nEach province and territory has their own rules.\u00a0 Some provincial drug plans provide coverage for individuals 65 and older, or those on social assistance.\u00a0 Some provinces (e.g. Ontario) provide special support to low-income individuals. Please call your Provincial Ministry or Department of Health to get more information about the terms of the publicly funded drug plan in your province. (see links on page 13 of the \u201cHow To Health Guide\u201d)\r\n\r\n<strong>Quebec public drug program<\/strong>\r\nIn Quebec, everyone must be covered by prescription drug insurance either through private or publicly funded plans.\r\n\r\nEach provincial and territorial government offers a drug benefit plan for eligible groups. Some are income-based universal programs. Most have specific programs for population groups that may require more enhanced coverage for high drug costs. These groups include seniors, recipients of social assistance, and individuals with diseases or conditions that are associated with high drug costs. For more details, please contact your provincial or territorial health care ministry, or click on the appropriate link below.\r\n\r\n\u2022 Alberta(Prescription Drug Programs)\r\n\u2022 British Columbia\u00a0(Pharmacare)\r\n\u2022 Manitoba\u00a0<a href=\"http:\/\/www.gov.mb.ca\/health\/pharmacare\/index.html\" rel=\"noopener\">(Pharmacare Program)<\/a>\r\n\u2022 New Brunswick\u00a0(Prescription Drug Program)\r\n\u2022 Newfoundland\u00a0<a href=\"http:\/\/www.health.gov.nl.ca\/health\/prescription\/\" rel=\"noopener\">(Pharmaceutical Services)<\/a>\r\n\u2022 Northwest Territories\u00a0<a href=\"http:\/\/www.hss.gov.nt.ca\/en\/services\/supplementary-health-benefits\/extended-health-benefits-specified-disease-conditions\" rel=\"noopener\">(Drug coverage)<\/a>\r\n\u2022 Nova Scotia\u00a0<a href=\"http:\/\/www.gov.ns.ca\/health\/pharmacare\/\" rel=\"noopener\">(Pharmacare)<\/a>\r\n\u2022 Nunavut\u00a0<a href=\"https:\/\/gov.nu.ca\/health\/information\/extended-health-benefits-ehb-eligible-specified-conditions\" rel=\"noopener\">(<\/a>Drug coverage<a href=\"https:\/\/gov.nu.ca\/health\/information\/extended-health-benefits-ehb-eligible-specified-conditions\" rel=\"noopener\">)<\/a>\r\n\u2022 Ontario\u00a0(Drug Benefit Program)\r\n\u2022 Prince Edward Island\u00a0<a href=\"http:\/\/www.healthpei.ca\/index.php3?number=1026180&amp;lang=E\" rel=\"noopener\">(Drug Cost Assistance Programs)<\/a>\r\n\u2022 Quebec\u00a0<a href=\"http:\/\/www.ramq.gouv.qc.ca\/en\/citizens\/prescription-drug-insurance\/pages\/prescription-drug-insurance.aspx\" rel=\"noopener\">(Prescription Drug Insurance)<\/a>\r\n\u2022 Saskatchewan\u00a0<a href=\"http:\/\/www.saskatchewan.ca\/residents\/health\/prescription-drug-plans-and-health-coverage\/extended-benefits-and-drug-plan\" rel=\"noopener\">(Drug Plan)<\/a>\r\n\u2022 Yukon\u00a0<a href=\"http:\/\/www.hss.gov.yk.ca\/insuredservices.php\" rel=\"noopener\">(Insured Health)<\/a>\r\n\r\n<strong>Pharmaceutical companies<\/strong>\r\nSome pharmaceutical companies provide medications to patients who cannot afford them or who do not have government or private insurance under the Compassionate Use Programs. Each program has its own terms for eligibility. Please talk to your doctor to see if you are eligible for such a program.\r\n\r\n<em>Available Patient Assistance Program for Primary Biliary Cholangitis treatment<\/em>\r\n\u2022 NAVIGATE Patient Support Program\u00a01 (844) 628-4484\r\n\u2013 OCALIVA (Obeticholic acid)\r\n<h2><strong>How do I take care of myself?<\/strong><\/h2>\r\nThere are a number of treatments for the symptoms of PBC.\r\n\r\n<strong>Itchy skin:<\/strong>\u00a0Cholestyramine may be prescribed by your doctor to help ease itching. Cholestyramine is taken orally and works by preventing re-absorption of the chemicals (bile acids) that cause the itching. Sometimes rifampicin, naltrexone or sertraline may be prescribed by your doctor. In addition to medications, a skin moisturizer may be beneficial as itching is made worse by dry skin. As well, avoid taking hot baths and hot showers which may dry out your skin further.\r\n\r\n<strong>Dry eyes and dry mouth<\/strong>\u00a0may be relieved by artificial tears and saliva, lubricating gels and creams. Sugarless lozenges and gum may help with the dryness in your mouth. Good dental hygiene is very important. Biot\u00e8ne\u00ae products may also be helpful for dry mouth.\r\n\r\n<strong>Diet<\/strong>: A healthy diet is important to liver health. Specific things to keep in mind include:\r\n<ul>\r\n \t<li>Maintain a\u00a0<a href=\"http:\/\/www.hc-sc.gc.ca\/fn-an\/food-guide-aliment\/basics-base\/quantit-eng.php\" rel=\"noopener\">healthy caloric intake<\/a>\u00a0recommended for your age, gender and activity level.<\/li>\r\n \t<li>Eat from all four food groups, including fruits and vegetables, whole grains and cereals, milk products and meats and alternatives.<\/li>\r\n \t<li>Limit your intake of salty, sugary and fatty foods.<\/li>\r\n<\/ul>\r\n<strong>Alcohol can damage your liver<\/strong>. If you have a liver disease, you should avoid drinking alcohol.\r\n<strong>\r\nTaking medication:<\/strong>\u00a0Talk to your healthcare provider before taking any medicine or treatment, including over-the-counter supplements and herbal remedies. Many medicines may have unwanted side effects and interactions.\r\n\r\n<strong>Dealing with fatigue:<\/strong>\u00a0The cause of fatigue in PBC is unknown. It is important for your doctor to rule out other potential non-PBC -related causes of fatigue, including anemia and thyroid problems. If you feel tired and unable to carry out day-to-day tasks, you may find that some lifestyle changes can make a difference:\r\n<ul>\r\n \t<li>Pace your activities.<\/li>\r\n \t<li>Try daily aerobic physical activities such as walking and swimming to help make you more fit without becoming exhausted.<\/li>\r\n \t<li>Adjust your hobbies and daily activities to more closely match your energy level.<\/li>\r\n<\/ul>\r\n<strong>Bone health:<\/strong>\u00a0As we get older our bones often become thinner and more brittle. This is more common among women, especially after menopause. PBC may make this worse. You can help prevent this problem by doing plenty of weight-bearing exercises and eating food with plenty of calcium (dairy products such as milk). Sometimes, despite these efforts, medicine may be needed. All Canadians should take a vitamin D supplement (1,000 \u2013 2,000 IU\/day). You may be advised to take calcium supplements. \u00a0As well, your healthcare provider may recommend bone enhancing medication or hormone replacement therapy.\r\n\r\nSome complementary and alternative medicines may possibly help with the symptoms of liver disease, but many can damage the liver. More research is needed in order to assess the role of complementary and alternative medicine in liver disease. Please discuss the use of these therapies with your healthcare provider.\r\n\r\n<strong>What lifestyle changes may be helpful for PBC patients?\r\n<\/strong>The prognosis of PBC varies greatly from one patient to another. Many lead active lives with few symptoms for more than 10 to 20 years (and even longer). In some patients, however, the condition progresses more rapidly and liver deterioration may occur in just a few years. There is a healthy way to live with a chronic disease and you are encouraged to maintain an active lifestyle under the supervision of your healthcare provider. It is important to know that support is available that may help you improve your quality of life. In consultation with your healthcare provider, you should do your best to:\r\n<ul>\r\n \t<li>Maintain a healthy lifestyle<\/li>\r\n \t<li>Reduce stress<\/li>\r\n \t<li>Be physically active<\/li>\r\n<\/ul>\r\n<h2><strong>Resources<\/strong><\/h2>\r\n<strong><a href=\"https:\/\/liver.ca\/wp-content\/uploads\/2018\/08\/EASL_PBC_Patient-Guidelines_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Primary biliary cholangitis (PBC)<\/a>\u00a0<a href=\"https:\/\/liver.ca\/wp-content\/uploads\/2018\/08\/EASL_PBC_Patient-Guidelines_ENG.pdf\"><img class=\"alignright size-medium wp-image-13879\" src=\"https:\/\/liver.ca\/wp-content\/uploads\/2018\/08\/PBC-Guide-2018-213x300.png\" sizes=\"(max-width: 213px) 100vw, 213px\" srcset=\"https:\/\/liver.ca\/wp-content\/uploads\/2018\/08\/PBC-Guide-2018-213x300.png 213w, https:\/\/liver.ca\/wp-content\/uploads\/2018\/08\/PBC-Guide-2018.png 573w\" alt=\"pbcguide\" width=\"213\" height=\"300\" \/><\/a>\r\n<\/strong>\r\n\r\n<strong><em>Living with your diagnosis<\/em><\/strong>\r\nThe European Association for the Study of the Liver (EASL) is a major European Association with international influence, dedicated to the study of the liver and liver disease. A group of international PBC patient groups worked together to create this guide to help patients diagnosed with primary biliary cholangitis (PBC) understand the EASL clinical guidelines for this condition, and to demonstrate the importance of a structured, life-long and personalised approach to their care.","remove_heading_underline":false}],"related_resources":"","title":"Cholangite biliaire primitive","text":"","image":"","landing_page":false},"_links":{"self":[{"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/resource\/1738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"acf:term":[{"embeddable":true,"taxonomy":"resource-topic","href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/resource-topic\/47"},{"embeddable":true,"taxonomy":"resource-type","href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/resource-type\/73"}],"wp:attachment":[{"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/media?parent=1738"}],"wp:term":[{"taxonomy":"resource-topic","embeddable":true,"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/resource-topic?post=1738"},{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/liver.ca\/fr\/wp-json\/wp\/v2\/resource-type?post=1738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}